ClinicalTrials.Veeva

Menu

Effect of a Short Nap During the Night Shift of Healthcare Workers on Endothelial Function (NAP-WORK)

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Enrolling

Conditions

Healthy Volonteers

Treatments

Other: Pichot fatigue scale
Other: The Short-Form 36 (SF-36)
Other: Pittsburgh Sleep Quality Index (PSQI)
Device: Popmeter®
Behavioral: Control condition (30-min rest)
Behavioral: On-duty Nap
Biological: Fasting blood sample
Other: French version of the Recovery Needs Scale (BRD)
Other: Epworth questionnaire
Device: ECG Holter
Device: Actimeter
Device: Panasonic EW3109
Device: EndoPAT
Other: The Karolinska Sleepiness Scale

Study type

Interventional

Funder types

Other

Identifiers

NCT05955729
2023-A01109-36 (Other Identifier)
23CH138

Details and patient eligibility

About

Night shift work is well known to cause health disruption in short and long term. It has been reported that among healthcare workers, nurses slept less than 6 h/24h. Consequences of such short sleep duration has been associated to long term issues such as endothelial dysfunction associated with cardiovascular diseases, arterial hypertension and type 2 diabetes. Countermeasures such as nap at work has potential effects on reducing the prevalence of cardiovascular diseases. However, to our knowledge, no studies have objectively investigated the effects of napping on endothelial function in a longitudinal design. Therefore, this study aims to investigate the effect of a 30 minutes on-duty nap during night work for 12 weeks on caregivers endothelial dysfunction.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Being a paramedical caregiverr (nurse or care assistant) at Saint-Etienne University Hospital
  • Be aAged between 18 and 65
  • Working at least 80% of a full-time equivalent post
  • Working 12-hour shifts (day/night) in continuous care services
  • Being affiliated or entitled under a social security scheme
  • Havinge received informed information about the study and have co-signed, with the investigator, a consent to participate in the study

Exclusion criteria

  • Have made a tTrans meridian journey in the last month prior to the study
  • Have a mMedically diagnosed sleep disorder such asof the hypersomnia or insomnia type
  • Have a diagnosed and treated mental pathology
  • Usually take a nap in the workplace in a quiet room
  • Be pregnant or breastfeeding
  • Have medically diagnosed neurovascular or neuromuscular pathologies

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

Nap group
Experimental group
Description:
The experimental group will be allocated to do a 30-min on-duty nap during night work, in a dedicated room between 1 am and 4 am.
Treatment:
Other: The Karolinska Sleepiness Scale
Device: EndoPAT
Device: Panasonic EW3109
Device: Actimeter
Device: ECG Holter
Other: Epworth questionnaire
Other: French version of the Recovery Needs Scale (BRD)
Biological: Fasting blood sample
Behavioral: On-duty Nap
Device: Popmeter®
Other: Pittsburgh Sleep Quality Index (PSQI)
Other: The Short-Form 36 (SF-36)
Other: Pichot fatigue scale
Control group
Active Comparator group
Description:
The control group will be allocated to rest in a dedicated room without napping between 1 am and 4 am.
Treatment:
Other: The Karolinska Sleepiness Scale
Device: EndoPAT
Device: Panasonic EW3109
Device: Actimeter
Device: ECG Holter
Other: Epworth questionnaire
Other: French version of the Recovery Needs Scale (BRD)
Biological: Fasting blood sample
Behavioral: Control condition (30-min rest)
Device: Popmeter®
Other: Pittsburgh Sleep Quality Index (PSQI)
Other: The Short-Form 36 (SF-36)
Other: Pichot fatigue scale

Trial contacts and locations

1

Loading...

Central trial contact

Frédéric ROCHE, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems